Caredx Additional Paid In Capital from 2010 to 2025
| CDNA Stock | USD 22.70 0.89 3.77% |
Additional Paid In Capital | First Reported 2010-12-31 | Previous Quarter 303.8 M | Current Value 319 M | Quarterly Volatility 136.6 M |
Check Caredx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caredx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.9 M, Interest Expense of 3.7 M or Selling General Administrative of 142.3 M, as well as many indicators such as Price To Sales Ratio of 1.97, Dividend Yield of 0.0 or PTB Ratio of 1.11. Caredx financial statements analysis is a perfect complement when working with Caredx Valuation or Volatility modules.
Caredx | Additional Paid In Capital |
Latest Caredx's Additional Paid In Capital Growth Pattern
Below is the plot of the Additional Paid In Capital of Caredx Inc over the last few years. Additional Paid In Capital (or APIC) is an accounting term found on Caredx Inc Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x Caredx Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of Caredx Inc shares and does not have any impact on the value of APIC. It is the excess amount paid by investors over the par value of a company's shares, representing the additional capital contributed by shareholders. Caredx's Additional Paid In Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caredx's overall financial position and show how it may be relating to other accounts over time.
| Additional Paid In Capital | 10 Years Trend |
|
Additional Paid In Capital |
| Timeline |
Caredx Additional Paid In Capital Regression Statistics
| Arithmetic Mean | 169,247,621 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 80.72 | |
| Mean Deviation | 126,935,715 | |
| Median | 264,204,000 | |
| Standard Deviation | 136,612,637 | |
| Sample Variance | 18663T | |
| Range | 319M | |
| R-Value | 0.89 | |
| Mean Square Error | 4321.8T | |
| R-Squared | 0.78 | |
| Slope | 25,404,950 | |
| Total Sum of Squares | 279945.2T |
Caredx Additional Paid In Capital History
About Caredx Financial Statements
Caredx stakeholders use historical fundamental indicators, such as Caredx's Additional Paid In Capital, to determine how well the company is positioned to perform in the future. Although Caredx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Caredx's assets and liabilities are reflected in the revenues and expenses on Caredx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Caredx Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Additional Paid In Capital | 303.8 M | 319 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out the analysis of Caredx Correlation against competitors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share | Quarterly Revenue Growth 0.234 | Return On Assets | Return On Equity |
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.